Guffon, N., Bröijersén, A., Palmgren, I., Rudebeck, M., & Olsson, B. (2017). Open-Label Single-Sequence Crossover Study Evaluating Pharmacokinetics, Efficacy, and Safety of Once-Daily Dosing of Nitisinone in Patients with Hereditary Tyrosinemia Type 1. JIMD Rep.
Citação norma ChicagoGuffon, Nathalie, Anders Bröijersén, Ingrid Palmgren, Mattias Rudebeck, and Birgitta Olsson. "Open-Label Single-Sequence Crossover Study Evaluating Pharmacokinetics, Efficacy, and Safety of Once-Daily Dosing of Nitisinone in Patients With Hereditary Tyrosinemia Type 1." JIMD Rep 2017.
Citação norma MLAGuffon, Nathalie, et al. "Open-Label Single-Sequence Crossover Study Evaluating Pharmacokinetics, Efficacy, and Safety of Once-Daily Dosing of Nitisinone in Patients With Hereditary Tyrosinemia Type 1." JIMD Rep 2017.